FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2259593390> ?p ?o ?g. }

• W2259593390 endingPage "511" @default.
• W2259593390 startingPage "505" @default.
• W2259593390 abstract "<h3>Objectives</h3> We aimed to compare progression-free survival (PFS) and overall survival (OS) among patients with stage I-to-IV uterine leiomyosarcoma (uLMS) who received adjuvant gemcitabine-docetaxel, were observed, received radiation only, or were treated with a chemotherapy regimen other than gemcitabine-docetaxel. <h3>Methods/Materials</h3> This is a retrospective cohort study of 128 women with uLMS. Data included age, body mass index, race, stage, mitotic count, residual disease, adjuvant treatment, PFS, and OS. Variables were compared by Fisher exact or Wilcoxon rank-sum tests. Time to progression or death was plotted using Kaplan-Meier curves. Cox proportional hazards regression was used to estimate hazard ratios for progression or death by patient and tumor characteristics. <h3>Results</h3> Fifty-six (44%) women received adjuvant chemotherapy, 41 (32%) received adjuvant radiation, and 31 (24%) were observed. Of those receiving chemotherapy, 30 received gemcitabine-docetaxel, and 26 received other chemotherapy. Disease stage for the chemotherapy groups was evenly distributed. In the radiation group, 80% of patients had early-stage disease. Age, body mass index, and residual disease were similar between the groups. Mitotic count was uniformly 10 or greater only in the gemcitabine-docetaxel group. Age, stage, and residual disease were associated with worst PFS and OS. After adjusting for these variables, there was no difference in PFS or OS between gemcitabine-docetaxel and the other treatment groups. <h3>Conclusions</h3> There was no difference in PFS or OS in women with uLMS treated with adjuvant gemcitabine-docetaxel versus those who were observed or received radiation only or a chemotherapy regimen other than gemcitabine-docetaxel. There is a need to identify novel therapies to treat this aggressive disease." @default.
• W2259593390 created "2016-06-24" @default.
• W2259593390 creator A5019160700 @default.
• W2259593390 creator A5027959749 @default.
• W2259593390 creator A5034016202 @default.
• W2259593390 creator A5039658238 @default.
• W2259593390 creator A5063523041 @default.
• W2259593390 creator A5064292507 @default.
• W2259593390 creator A5067236666 @default.
• W2259593390 creator A5068522544 @default.
• W2259593390 creator A5074712841 @default.
• W2259593390 date "2016-03-01" @default.
• W2259593390 modified "2023-10-01" @default.
• W2259593390 title "Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma" @default.
• W2259593390 cites W1489305676 @default.
• W2259593390 cites W1998248038 @default.
• W2259593390 cites W1999182288 @default.
• W2259593390 cites W2004001144 @default.
• W2259593390 cites W2033329597 @default.
• W2259593390 cites W2035026998 @default.
• W2259593390 cites W2054993302 @default.
• W2259593390 cites W2069693587 @default.
• W2259593390 cites W2077295631 @default.
• W2259593390 cites W2082479412 @default.
• W2259593390 cites W2104793343 @default.
• W2259593390 cites W2106971844 @default.
• W2259593390 cites W2119679072 @default.
• W2259593390 cites W2136309235 @default.
• W2259593390 cites W2157400532 @default.
• W2259593390 cites W2167352270 @default.
• W2259593390 cites W2236777922 @default.
• W2259593390 cites W2314973812 @default.
• W2259593390 cites W2325172660 @default.
• W2259593390 cites W2465632965 @default.
• W2259593390 doi "https://doi.org/10.1097/igc.0000000000000634" @default.
• W2259593390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26807641" @default.
• W2259593390 hasPublicationYear "2016" @default.
• W2259593390 type Work @default.
• W2259593390 sameAs 2259593390 @default.
• W2259593390 citedByCount "17" @default.
• W2259593390 countsByYear W22595933902016 @default.
• W2259593390 countsByYear W22595933902017 @default.
• W2259593390 countsByYear W22595933902018 @default.
• W2259593390 countsByYear W22595933902019 @default.
• W2259593390 countsByYear W22595933902020 @default.
• W2259593390 countsByYear W22595933902021 @default.
• W2259593390 crossrefType "journal-article" @default.
• W2259593390 hasAuthorship W2259593390A5019160700 @default.
• W2259593390 hasAuthorship W2259593390A5027959749 @default.
• W2259593390 hasAuthorship W2259593390A5034016202 @default.
• W2259593390 hasAuthorship W2259593390A5039658238 @default.
• W2259593390 hasAuthorship W2259593390A5063523041 @default.
• W2259593390 hasAuthorship W2259593390A5064292507 @default.
• W2259593390 hasAuthorship W2259593390A5067236666 @default.
• W2259593390 hasAuthorship W2259593390A5068522544 @default.
• W2259593390 hasAuthorship W2259593390A5074712841 @default.
• W2259593390 hasConcept C126322002 @default.
• W2259593390 hasConcept C143998085 @default.
• W2259593390 hasConcept C207103383 @default.
• W2259593390 hasConcept C2776694085 @default.
• W2259593390 hasConcept C2780258809 @default.
• W2259593390 hasConcept C2781190966 @default.
• W2259593390 hasConcept C2781413609 @default.
• W2259593390 hasConcept C44249647 @default.
• W2259593390 hasConcept C71924100 @default.
• W2259593390 hasConceptScore W2259593390C126322002 @default.
• W2259593390 hasConceptScore W2259593390C143998085 @default.
• W2259593390 hasConceptScore W2259593390C207103383 @default.
• W2259593390 hasConceptScore W2259593390C2776694085 @default.
• W2259593390 hasConceptScore W2259593390C2780258809 @default.
• W2259593390 hasConceptScore W2259593390C2781190966 @default.
• W2259593390 hasConceptScore W2259593390C2781413609 @default.
• W2259593390 hasConceptScore W2259593390C44249647 @default.
• W2259593390 hasConceptScore W2259593390C71924100 @default.
• W2259593390 hasIssue "3" @default.
• W2259593390 hasLocation W22595933901 @default.
• W2259593390 hasLocation W22595933902 @default.
• W2259593390 hasOpenAccess W2259593390 @default.
• W2259593390 hasPrimaryLocation W22595933901 @default.
• W2259593390 hasRelatedWork W1986102760 @default.
• W2259593390 hasRelatedWork W2080820783 @default.
• W2259593390 hasRelatedWork W2117311151 @default.
• W2259593390 hasRelatedWork W2151941897 @default.
• W2259593390 hasRelatedWork W2315587357 @default.
• W2259593390 hasRelatedWork W2369970408 @default.
• W2259593390 hasRelatedWork W2380347422 @default.
• W2259593390 hasRelatedWork W2380565576 @default.
• W2259593390 hasRelatedWork W2386316807 @default.
• W2259593390 hasRelatedWork W4241962006 @default.
• W2259593390 hasVolume "26" @default.
• W2259593390 isParatext "false" @default.
• W2259593390 isRetracted "false" @default.
• W2259593390 magId "2259593390" @default.
• W2259593390 workType "article" @default.